Benedetti MS - Search Results

1

Determination of exemestane, a new aromatase inhibitor, in plasma by high-performance liquid chromatography with ultraviolet detection.

Breda M, Pianezzola E, Benedetti MS. Breda M, et al. Among authors: benedetti ms. J Chromatogr. 1993 Oct 29;620(2):225-31. doi: 10.1016/0378-4347(93)80008-r. J Chromatogr. 1993. PMID: 8300790

2

Determination of 3'-deamino-3'-[2(S)-methoxy-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detection.

Breda M, Pianezzola E, Benedetti MS. Breda M, et al. Among authors: benedetti ms. J Chromatogr. 1992 Jul 24;578(2):309-15. doi: 10.1016/0378-4347(92)80431-o. J Chromatogr. 1992. PMID: 1400812

3

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women.

Evans TR, Di Salle E, Ornati G, Lassus M, Benedetti MS, Pianezzola E, Coombes RC. Evans TR, et al. Among authors: benedetti ms. Cancer Res. 1992 Nov 1;52(21):5933-9. Cancer Res. 1992. PMID: 1394219 Clinical Trial.

4

Effect of rifabutin on ethambutol pharmacokinetics in healthy volunteers.

Breda M, Benedetti MS, Bani M, Pellizzoni C, Poggesi I, Brianceschi G, Rocchetti M, Dolfi L, Sassella D, Rimoldi R. Breda M, et al. Among authors: benedetti ms. Pharmacol Res. 1999 Oct;40(4):351-6. doi: 10.1006/phrs.1999.0526. Pharmacol Res. 1999. PMID: 10527648 Clinical Trial.

5

Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.

Breda M, Benedetti MS, Battaglia R, Castelli MG, Poggesi I, Spinelli R, Hackett AM, Dostert P. Breda M, et al. Among authors: benedetti ms. Pharmacol Res. 2000 Feb;41(2):239-48. doi: 10.1006/phrs.1999.0584. Pharmacol Res. 2000. PMID: 10623492

6

The disposition and urinary metabolism of 14C-labelled FCE 22891, a pro-drug of FCE 22101, in animals.

Battaglia R, Benedetti MS, Frigerio E, Vicario G, Roncucci R. Battaglia R, et al. Among authors: benedetti ms. J Antimicrob Chemother. 1990 Jan;25(1):133-9. doi: 10.1093/jac/25.1.133. J Antimicrob Chemother. 1990. PMID: 2318748

7

Excretion balance and urinary metabolic pattern of [3H]cabergoline in man.

Cocchiara G, Benedetti MS. Cocchiara G, et al. Among authors: benedetti ms. Drug Metabol Drug Interact. 1992;10(3):199-211. doi: 10.1515/dmdi.1992.10.3.199. Drug Metabol Drug Interact. 1992. PMID: 1424641

8

Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose.

Jannuzzo MG, Mandelli M, Benedetti MS, Moro E, Carnovali M, Vaiani R, Sassella D. Jannuzzo MG, et al. Among authors: benedetti ms. Eur J Clin Pharmacol. 1989;36(6):633-5. doi: 10.1007/BF00637750. Eur J Clin Pharmacol. 1989. PMID: 2776823

9

Review of the pharmacokinetics and metabolism of reboxetine, a selective noradrenaline reuptake inhibitor.

Dostert P, Benedetti MS, Poggesi I. Dostert P, et al. Among authors: benedetti ms. Eur Neuropsychopharmacol. 1997 Apr;7 Suppl 1:S23-35; discussion S71-3. doi: 10.1016/s0924-977x(97)00417-3. Eur Neuropsychopharmacol. 1997. PMID: 9169308 Review.

10

Metabolic fate of FCE 22716, a new antihypertensive agent, and of its N-oxide (FCE 24220) in the rat.

Cocchiara G, Battaglia R, Fontana E, Benedetti MS. Cocchiara G, et al. Among authors: benedetti ms. Drug Metabol Drug Interact. 1992;10(3):185-97. doi: 10.1515/dmdi.1992.10.3.185. Drug Metabol Drug Interact. 1992. PMID: 1424640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters